US ADP private payrolls beat expectations and increased by 692k vs estimates of 550k. Cyclical stocks closed higher on Wednesday – Energy was up 1.3% and Industrials up 0.8%, while IT was marginally down 0.1%. S&P extended gains to the fifth consecutive month, up 14% YTD. Nasdaq on the other hand was down 0.2%, ending the first half of the year up 12%. US markets remained near record highs with the S&P gaining 0.1%. With XPeng planning to transfer some of its shares from the Cayman register to the Hong Kong register, this will make it a lot easier for the stock to be included in the HSCI (and consequently into Southbound Stock Connect) earlier.Ī change to secondary-listing treatment could also make it possible for inclusion in the Hang Seng China Enterprises Index (HSCEI INDEX) at an earlier point in time. The earliest inclusion in the HSCI could happen at the December quarterly review if the oversubscription option is exercised and if there is an increase in the stock price.Īn alternative is for XPeng to apply to the Hang Seng Indexes (HSIL) for treatment as a Secondary Listed company. We do not expect XPeng to be included in the Hang Seng Composite Index (HSCI) via Fast Entry. The stock is expected to start trading on the HKEX on 7 July under the ticker ‘9868’.įTSE has announced an increase in the number of issued shares and passive funds will need to buy Xpeng (XPEV US) at the close of trading on 7 July in the US.Īs a dual primary listing, only the shares issued in Hong Kong will be used in the calculation of the market cap for inclusion in the various indices. There is an oversubscription option for another 12.75m shares. The company also focuses on providing solutions in the field of major diseases, especially oncology and rare diseases.Īfter this round of financing, LinkDoc will connect all kinds of online and offline resources to establish a service loop, and benefit more patients, based on its advantages in data management, auxiliary diagnosis and treatment, scientific research services, patient management, doctor operation, and drug distribution in the vertical field of oncology.Xpeng (XPEV US) is raising US$1.8bn via a dual primary listing on the HKEX (388 HK) by selling 85m shares at HK$165/share. At present, its main business includes real-world pharmaceutical researches, patient health management, patient recruitment, etc. With the mission of "Care Data Care Life", LinkDoc provides the overall solution of big data and AI for all parties in the pharmaceutical and medical industry. LinkDoc is committed to the R&D of big data and artificial intelligence (AI). This strategic investment in LinkDoc is Ali Health's new scheme in the field of major diseases, which demonstrates Ali Health's determination to promote medical care of serious diseases with innovative Internet technologies. Through the layout of "having good drugs, famous doctors and guarantee", Ali Health uses the Internet model and technological innovation to promote the development of scientific research, diagnosis and treatment of major diseases, genetic testing, biological vaccines, and other fields. With the "Internet + Medicine" strategy, Ali Health has established a reliable and inclusive medical service system. Under the background of encouraging the innovative development of medical and healthcare enterprises, Ali Health actively expands its business to meet the diversified medical and healthcare needs of more patients. The two companies will build a patient-centered and technological innovation-driven full-disease cycle service platform for Chinese oncology patients, actively explore innovative online service mode of oncology specialty drugs, and create an online and offline oncology specialty medical service system, to provide patients with high-quality medical services covering the entire disease cycle, from treatment to medicine. 4, 2021 - LinkDoc Technology ("LinkDoc"), a Chinese company focusing on big data in medicine, recently announced it has received a strategic investment from Ali Health.
0 Comments
Leave a Reply. |